
LIVE TOMORROW: Sugar Queens S3E6 ➡️ mdsc.pe/4AqhvOO Learn practical strategies to interpret low glucose alerts and tackle overnight hypoglycemia risk. 🗓️ Nov 19th ⏰ 3:30pm ET #Diabetes #CME #Healthcare #SugarQueens

Medscape provides breaking medical news and expert perspectives, drug and disease information, and free CME across 30+ medical specialties.

LIVE TOMORROW: Sugar Queens S3E6 ➡️ mdsc.pe/4AqhvOO Learn practical strategies to interpret low glucose alerts and tackle overnight hypoglycemia risk. 🗓️ Nov 19th ⏰ 3:30pm ET #Diabetes #CME #Healthcare #SugarQueens

World COPD Day: "Short of Breath, Think COPD." Prompt action on breathlessness enables earlier treatment and prevention. Healthcare, communities, and leaders: – unite for access. mdsc.pe/3ZYMDV5

Once an orphan disease that drew little research attention, hidradenitis suppurativa is now the focus of hundreds of recent papers and dozens of potential therapies. What can this journey teach us? mdsc.pe/4eHa9hp

Which patients with metabolic disease should you screen for MASH? In episode 3 of Managing MASH in the Modern Era, Dr. Priya Jaisinghani discusses where screening fits in endocrinology practice. 🔗 mdsc.pe/4ek2FR7

Recently, a major betting platform called Kashi started letting users bet on whether new medical treatments will succeed in clinical trials. In response, doctors and medical researchers are speaking out about this, warning that research centers would have to spend more time and money enforcing red tape in an effort to safeguard patients' trust. Clinical trials rely on volunteers. Without new laws banning these bets, patients' may be less likely to volunteer for clinical trials and extra red tape could slow down the release of new medicine. Kalshi argues that doctors are overreacting, are regulated by the federal government, and have added safety rules to protect traders and patients alike. To learn more about how it started and what happens next, tap the link: mdsc.pe/4jp8O1a

How does mNGS fit into your diagnostic approach? Join experts to review available tests and best-use practices for evaluating suspected infections in immunocompromised patients. 🔗 mdsc.pe/4yt5g3c

If you find it hard to keep patients exercising, you’re not alone: even in carefully designed studies, attrition ranges from 25% to 50%, and those who finish adhere only about 66% of the time. Motivational messages usually focus on the benefits of starting, such as a stronger heart, better balance, lower blood pressure, and improved brain health. But what happens when you stop? That may or may not motivate someone, but understanding the cellular effects of quitting could help patients recovering from injury or surgery, undergoing cancer treatment, or on bed rest, as well as people taking a break after a goal like a marathon. Tap the link to read more: mdsc.pe/3U9RqE6

COPD Day: Spread the word—breathing problems deserve attention. Screen symptomatic/high-risk patients, promote smoking cessation, counsel on pollutant avoidance, and optimize inhaler regimens. Early recognition, treatment, and prevention make a difference. mdsc.pe/4aOwV5q

The best diet for MASH is the one your patients can actually stick to. Dr. Naim Alkhouri shares how he uses AI to tailor heart-healthy Mediterranean diets to fit patients' cultural food preferences. Watch the full discussion ➡️ mdsc.pe/4iLaXEl #CME #MASH #Hepatology

Regulators in Australia have updated psychedelic medicine guidelines, but disagreements persist about who can and can’t lead therapy sessions. mdsc.pe/4jkfZrr

A retained spilled gallstone following laparoscopic cholecystectomy can cause a delayed perihepatic abscess and present with persistent thoracic pain and recurrent fever. This case highlights the importance of considering previous surgical complications when investigating unexplained symptoms and reassessing imaging findings when the initial clinical assessment does not establish a diagnosis. The case report by Alaa Kansoun, MD, and colleagues at Hôpital Saint Joseph in Marseille, France, described this rare complication and its management. Read more: mdsc.pe/4zuM1Ga

Some of medicine’s biggest breakthroughs began with a researcher using their own body as the experiment. From a catheter threaded into a heart to a drink of bacteria, here are 9 daring self-experiments, and why they’d never pass ethics review today: mdsc.pe/48ksD3F

Despite widespread awareness that broad food allergy panels frequently produce false-positive results, clinicians continue to order the tests for patients with conditions such as eczema and hives, according to a survey presented at the American College of Allergy, Asthma and Immunology (ACAAI) 2026 Annual Meeting. In the survey, 85% of clinicians recognized that food allergy panels have high false-positive rates, yet many reported ordering them for indications that experts do not recommend. mdsc.pe/4t7Oc11

Two patient cases. One important clinical question: How confidently can you apply the hormone therapy (HT) timing hypothesis in menopause care? Explore the two case studies: A postmenopausal woman with vasomotor symptoms and osteopenia A 48-year-old woman with surgical menopause Test your knowledge and build confidence in applying the hormone therapy (HT) timing hypothesis to real-world clinical scenarios. Access the free accredited CME now: mdsc.pe/4t61z0P

A large comparative study of antidepressant medication has identified the drugs’ ability to achieve and sustain improvements in patients with major depressive disorder (MDD). The analysis showed that escitalopram, duloxetine, and agomelatine were associated with higher rates of sustained treatment response than those observed with fluoxetine. Escitalopram and duloxetine were also associated with lower rates of treatment discontinuation. “These results may have implications for future guidelines and for the choice of a first antidepressant,” first author Paul C.F. van Haaren, MD, MSc, of Radboud University Medical Center, Nijmegen, Netherlands, told Medscape Medical News. mdsc.pe/4t0Wrvv

The arrival of flu and COVID season once again brings to attention the fact that people with autoimmune and immune-mediated inflammatory diseases continue to be vaccinated at suboptimal rates despite their elevated risk for infection and poorer outcomes. In recent years, however, programs in rheumatology clinics have provided examples of successful approaches to address this problem against the headwinds of vaccine hesitancy and real-world challenges in implementing vaccination recommendations. And a national-level initiative is working to bring more evidence to the table to both prevent and treat infections in immunocompromised people. Tap the link to read more: mdsc.pe/3UU0bm7